Gadd45β silencing impaired viability and metastatic phenotypesin cholangiocarcinoma cells by modulating the emt pathway

by Kyaw Zwar Myint, Pornparn Kongpracha, Panthip Rattanasinganchan, Kawin Leelawat, Penpak Moolthiya, Kittipong Chaiyabutr, Rutaiwan Tohtong
Published 2019

Co-clinical trials: An innovative drug development platform for cholangiocarcinoma

by Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert, Supeecha Kumkate, David O. Bates, Rutaiwan Tohtong
Published 2022

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

by Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M. Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M. Grabowska, David O. Bates, Kanokpan Wongprasert
Published 2022